{"id":"https://openalex.org/W2762461685","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.11504","title":"Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.","display_name":"Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2762461685","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.11504","mag":"2762461685"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.11504","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.11504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.11504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084359163","display_name":"Niki Karachaliou","orcid":"https://orcid.org/0000-0002-2378-0498","observed_orcids":["https://orcid.org/0000-0002-2378-0498"]},"institutions":[{"id":"https://openalex.org/I4210133548","display_name":"Hospital Universitari Sagrat Cor","ror":"https://ror.org/03fzyry86","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133548"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Niki Karachaliou","raw_affiliation_strings":["Hospital Universitari Sagrat Cor - Grupo Quir\u00f3nsalud- Oncology Department, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari Sagrat Cor - Grupo Quir\u00f3nsalud- Oncology Department, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210133548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085476251","display_name":"Guillermo Crespo","orcid":"https://orcid.org/0000-0003-1802-4441","observed_orcids":["https://orcid.org/0000-0003-1802-4441"]},"institutions":[{"id":"https://openalex.org/I4210115949","display_name":"Hospital Universitario de Burgos","ror":"https://ror.org/01j5v0d02","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115949"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Guillermo Crespo","raw_affiliation_strings":["Hospital Universitario de Burgos, Burgos, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Burgos, Burgos, Spain;","institution_ids":["https://openalex.org/I4210115949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054348151","display_name":"Erika Aldeguer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika Aldeguer","raw_affiliation_strings":["Pangaea Oncology, Quir\u00f3n-Dexeus University Institute, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pangaea Oncology, Quir\u00f3n-Dexeus University Institute, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107904737","display_name":"Ana Drozdowskyj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087611","display_name":"Pivotal (Spain)","ror":"https://ror.org/0025ycf95","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210087611"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Drozdowskyj","raw_affiliation_strings":["Pivotal, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pivotal, Madrid, Spain;","institution_ids":["https://openalex.org/I4210087611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071798228","display_name":"Ana A. Gim\u00e9nez-Capit\u00e1n","orcid":"https://orcid.org/0000-0003-2575-1225","observed_orcids":["https://orcid.org/0000-0003-2575-1225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Gimenez Capitan","raw_affiliation_strings":["Pangaea Oncology, Quir\u00f3n-Dexeus University Institute, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pangaea Oncology, Quir\u00f3n-Dexeus University Institute, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003341992","display_name":"Cristina Teixid\u00f3","orcid":"https://orcid.org/0000-0002-7226-6567","observed_orcids":["https://orcid.org/0000-0002-7226-6567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristina Teixido","raw_affiliation_strings":["Pangaea Oncology, Quir\u00f3n-Dexeus University Institute, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pangaea Oncology, Quir\u00f3n-Dexeus University Institute, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056676096","display_name":"Miguel \u00c1ngel Molina\u2010Vila","orcid":"https://orcid.org/0000-0001-8866-9881","observed_orcids":["https://orcid.org/0000-0001-8866-9881"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Angel Molina-Vila","raw_affiliation_strings":["Pangaea Oncology, Quir\u00f3n-Dexeus University Hospital, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pangaea Oncology, Quir\u00f3n-Dexeus University Hospital, Laboratory of Cellular and Molecular Biology, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040541281","display_name":"Santiago Viteri","orcid":"https://orcid.org/0000-0002-7572-1123","observed_orcids":["https://orcid.org/0000-0002-7572-1123"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Santiago Viteri Ramirez","raw_affiliation_strings":["Quir\u00f3n Salud-Dexeus University Institute, IOR, Medical Oncology Department, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quir\u00f3n Salud-Dexeus University Institute, IOR, Medical Oncology Department, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107870648","display_name":"Daniela Morales-Espinosa","orcid":"https://orcid.org/0000-0002-0735-9134","observed_orcids":["https://orcid.org/0000-0002-0735-9134"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniela Morales-Espinosa","raw_affiliation_strings":["Quir\u00f3n Salud-Dexeus University Institute, IOR, Medical Oncology Department, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quir\u00f3n Salud-Dexeus University Institute, IOR, Medical Oncology Department, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065160249","display_name":"Mar\u00eda de los Llanos Gil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria de los Llanos Gil","raw_affiliation_strings":["Quir\u00f3n Salud-Dexeus University Institute, IOR, Medical Oncology Department, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quir\u00f3n Salud-Dexeus University Institute, IOR, Medical Oncology Department, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072143967","display_name":"Mar\u00eda Gonz\u00e1lez\u2010Cao","orcid":"https://orcid.org/0000-0003-3791-540X","observed_orcids":["https://orcid.org/0000-0003-3791-540X"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Gonzalez-Cao","raw_affiliation_strings":["Hospital Universitario Quiron Dexeus, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Quiron Dexeus, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028314830","display_name":"Salvador Mart\u00edn\u2010Algarra","orcid":"https://orcid.org/0000-0002-3109-8026","observed_orcids":["https://orcid.org/0000-0002-3109-8026"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Salvador Martin Algarra","raw_affiliation_strings":["Cl\u00ednica Universidad de Navarra, Pamplona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universidad de Navarra, Pamplona, Spain;","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071761676","display_name":"El\u00edsabeth P\u00e9rez-Ruiz","orcid":"https://orcid.org/0000-0001-7204-0800","observed_orcids":["https://orcid.org/0000-0001-7204-0800"]},"institutions":[{"id":"https://openalex.org/I4210087438","display_name":"Hospital Costa del Sol","ror":"https://ror.org/0065mvt73","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210087438"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elisabeth P\u00e9rez-Ruiz","raw_affiliation_strings":["Hospital Costa del Sol, Oncology Department, REDISSEC, Marbella, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Costa del Sol, Oncology Department, REDISSEC, Marbella, Spain;","institution_ids":["https://openalex.org/I4210087438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068684456","display_name":"Iv\u00e1n M\u00e1rquez\u2010Rodas","orcid":"https://orcid.org/0000-0002-2476-668X","observed_orcids":["https://orcid.org/0000-0002-2476-668X"]},"institutions":[{"id":"https://openalex.org/I2960094004","display_name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","ror":"https://ror.org/0111es613","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2960094004","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ivan Marquez Rodas","raw_affiliation_strings":["Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;","institution_ids":["https://openalex.org/I2960094004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055964030","display_name":"Delvys Rodr\u00edguez\u2010Abreu","orcid":"https://orcid.org/0000-0003-0506-1366","observed_orcids":["https://orcid.org/0000-0003-0506-1366"]},"institutions":[{"id":"https://openalex.org/I2799299272","display_name":"Hospital Universitario Insular de Gran Canaria","ror":"https://ror.org/04cbm7s05","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2799299272","https://openalex.org/I4210120310"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Delvys Rodriguez-Abreu","raw_affiliation_strings":["Hospital Universitavio Insular De Gran Canaria, Las Palmas, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitavio Insular De Gran Canaria, Las Palmas, Spain;","institution_ids":["https://openalex.org/I2799299272"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113983105","display_name":"Remei Blanco","orcid":"https://orcid.org/0000-0001-6748-0326","observed_orcids":["https://orcid.org/0000-0001-6748-0326"]},"institutions":[{"id":"https://openalex.org/I4210098336","display_name":"Consorci Sanitari de Terrassa","ror":"https://ror.org/01239b432","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210098336"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Remei Blanco","raw_affiliation_strings":["Consorcio Sanitario De Terrassa, Terrassa Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consorcio Sanitario De Terrassa, Terrassa Barcelona, Spain;","institution_ids":["https://openalex.org/I4210098336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053722517","display_name":"Teresa Pu\u00e9rtolas","orcid":"https://orcid.org/0000-0003-3908-9199","observed_orcids":["https://orcid.org/0000-0003-3908-9199"]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Teresa Puertolas","raw_affiliation_strings":["Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain;","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003668510","display_name":"Maria Angeles Royo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126200","display_name":"Hospital Universitario Doctor Peset","ror":"https://ror.org/03971n288","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210126200"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Angeles Royo","raw_affiliation_strings":["Hospital Dr Peset, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Dr Peset, Valencia, Spain;","institution_ids":["https://openalex.org/I4210126200"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044887899","display_name":"Rafael Rosell","orcid":"https://orcid.org/0000-0003-0817-3400","observed_orcids":["https://orcid.org/0000-0003-0817-3400"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rafael Rosell","raw_affiliation_strings":["Catalan Institute of Oncology, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Catalan Institute of Oncology, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210107147"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"11504","last_page":"11504"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9679999947547913},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":1.0},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8510000109672546},{"id":"https://openalex.org/keywords/stat3","display_name":"STAT3","score":0.6819999814033508},{"id":"https://openalex.org/keywords/ikbke","display_name":"IKBKE","score":0.8980000019073486},{"id":"https://openalex.org/keywords/stat1","display_name":"STAT1","score":0.9950000047683716},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.7850000262260437},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.6880000233650208},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.546999990940094},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6230000257492065},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6980000138282776},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.968999981880188},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8167375326156616},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7322080731391907},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6160812973976135},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5985672473907471},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5937376618385315},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5531529188156128},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47821351885795593},{"id":"https://openalex.org/C2777003663","wikidata":"https://www.wikidata.org/wiki/Q14912030","display_name":"STAT1","level":3,"score":0.47697433829307556},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.47689035534858704},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44595152139663696},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43775826692581177},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4187087416648865},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4060107171535492},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.3205649256706238},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2501440644264221}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.11504","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.11504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.11504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2794163856","https://openalex.org/W2768023768","https://openalex.org/W2978008319","https://openalex.org/W4378348559","https://openalex.org/W2946128306","https://openalex.org/W4366246377","https://openalex.org/W4239461311","https://openalex.org/W3031120600","https://openalex.org/W2796439452","https://openalex.org/W4379281114"],"abstract_inverted_index":{"11504":[0],"Background:":[1],"PD-L1":[2,89,93,240,262,285],"can":[3],"be":[4],"induced":[5],"by":[6,82],"oncogenic":[7],"signals":[8],"or":[9],"up-regulated":[10],"via":[11],"INFG":[12,39,163,184,204,227,260,298,325],"in":[13,41,52,96,156,177,243,311,320],"a":[14,215],"STAT1-":[15],"and":[16,54,65,76,88,98,110,239,245,261,269,276,278,313],"NF\u03baB-dependent":[17],"manner.":[18],"STAT3":[19,279],"opposes":[20],"STAT1-mediated":[21],"anti-tumor":[22],"immune":[23,99,246],"responses.":[24],"I":[25],"kappa":[26],"B":[27],"kinase":[28],"epsilon":[29],"(IKBKE)":[30],"is":[31,44,299,318,326],"an":[32,300],"interferon":[33],"signaling":[34],"inducer.":[35],"We":[36],"explored":[37],"whether":[38],"expression":[40,95,164,185,205,228,263,280,286],"pre-treatment":[42],"tumors":[43],"associated":[45],"with":[46,159,180,200,223,259,284],"to":[47,151,172,253,309,322],"the":[48,251],"efficacy":[49],"of":[50,59,307],"ICB":[51,310],"NSCLC":[53,75,120,157,221,312],"melanoma":[55,78,141,178,198,271,292,314],"patients.":[56,315],"The":[57,235],"role":[58],"inflammation-associated":[60],"transcription":[61],"factors":[62],"STAT3,":[63,85],"IKBKE":[64,255],"STAT1":[66,87],"was":[67,80,101,153,174,195,214,256,281],"also":[68],"examined.":[69,92],"Methods:":[70],"Total":[71],"RNA":[72],"from":[73],"17":[74,117],"21":[77,138],"patients,":[79],"analyzed":[81],"qRT-PCR.":[83],"INFG,":[84],"IKBKE,":[86],"mRNA":[90],"were":[91,114],"protein":[94,241],"tumor":[97,244],"cells":[100,247],"evaluated":[102],"(Ventana":[103],"SP142":[104],"assay).":[105],"Progression":[106],"free":[107],"survival":[108,112],"(PFS)":[109],"overall":[111],"(OS)":[113],"estimated.":[115],"Results:":[116],"previously":[118,139],"treated":[119,140],"patients":[121,142,158,179,199,222],"received":[122,143],"nivolumab;":[123],"71%":[124,127],"lung":[125],"adenocarcinoma,":[126],"male,":[128,146],"53%":[129],"smokers,":[130],"35%":[131],"KRAS":[132],"mutant,":[133],"88%":[134],"EGFR":[135],"wild-type":[136],"(wt).":[137],"pembrolizumab;":[144],"67%":[145,147],"BRAF":[148],"wt.":[149],"PFS":[150,171],"nivolumab":[152],"significantly":[154,175],"longer":[155,176,193,218],"high":[160,181,201,224],"vs.":[161,166,182,187,202,208,225,230],"low":[162,183,203,226],"(5.12":[165],"2mo,":[167],"p":[168,189,210,232],"=":[169,190,211,233,267,274,290,295],"0.0124).":[170],"pembrolizumab":[173],"(4.99":[186],"1.86mo,":[188],"0.0099).":[191],"Significantly":[192],"OS":[194,219],"observed":[196],"for":[197,217,220,303],"(not":[206],"reached":[207],"3.10mo":[209],"0.0183).":[212],"There":[213],"trend":[216],"(10.15":[229],"4.86mo,":[231],"0.0687).":[234],"other":[236],"gene":[237],"levels":[238,242],"did":[248],"not":[249],"affect":[250],"outcome":[252],"ICB.":[254],"positively":[257],"correlated":[258],"(NSCLC":[264,287],"Spearman\u2019s":[265,272,288],"\u03c1":[266,273,289,294],"0.58":[268],"0.65;":[270],"0.61":[275],"0.59),":[277],"loosely":[282],"anticorrelated":[283],"\u22120.21;":[291],"Pearson\u2019s":[293],"\u22120.01).":[296],"Conclusions:":[297],"important":[301],"marker":[302],"qRT-PCR":[304],"mediated":[305],"prediction":[306],"response":[308],"Further":[316],"research":[317],"warranted":[319],"order":[321],"validate":[323],"that":[324],"more":[327],"accurate":[328],"than":[329],"PD-L1.":[330]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2017-10-20T00:00:00"}